Skip to content
‹ Back to IndustriesHealthcare

The Future of Sanitation: Ionopure Pet Health Brings a New Level of Care to the World of Equine Sports

There are places we think of as clean and places we think of as less hygienic. Adella Thompson, an experienced horse trainer and enthusiast, has no doubt which category her favorite place is in. “I work in a barn,” Thompson said. “There’s a lot of manure and urine. There are horses everywhere. There are…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
The Future of Sanitation: Ionopure Pet Health Brings a New Level of Care to the World of Equine Sports

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

There are places we think of as clean and places we think of as less hygienic.

Adella Thompson, an experienced horse trainer and enthusiast, has no doubt which category her favorite place is in.

“I work in a barn,” Thompson said. “There’s a lot of manure and urine. There are horses everywhere. There are dogs everywhere. It’s a setting where you’re constantly cleaning out stalls, cleaning and grooming horses, feeding horses, watering horses, using buckets over and over again, and then caring for their medical needs.”

While pet owners are used to tricking their pooch or kitten into hopping in the car for a trip to the vet, a horse requires a vet to make house calls. That’s why Thompson, and many other horse-lovers, have learned so many tricks and tips on how to care for horses and take care of the smaller nicks and cuts suffered rather than constantly having a vet come to the stable.

Not long ago, Thompson noticed one of her horses suffered an injury at a show that required some attention. Fortunately, she had been turning to Ionogen products for some time and knew of a quick fix.

“She had a cut over her left eye. It didn’t require stitches, but it was deep, and it was bleeding. I immediately sprayed it with Ionopure Pet Health, and I watched the cut heal itself on its own,” she said.

John Shanahan, President and CEO of Ionogen, was pleased to hear of the product’s uses in the equine community, even if it wasn’t a use case he initially had in mind.

“We created Ionopure Pet Health because there was a gap for household pets in having products that could really be effective on things like hotspots, cuts and abrasions, and even rinsing the eyes and things like that,” he said. “There were other products that kind of existed in the space, but, in our opinion, they were too underpowered, they were too weak, and they didn’t actually perform and weren’t remaining stable enough for a long period of time.”

Ionopure Pet Health turned out not only to keep stable, but also to be effective in the stable, with its use in equine settings likely to continue for years to come.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512